GT Biopharma, Inc.
GTBP· Nasdaq
GTBPGT Biopharma, Inc.
Filed Mar 28, 2022 · 10-K · 87 days after period end · 0001493152-22-007883
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | — | — |
| Net Income | -$18.02M | -$6.29M | -$1.47M | -$4.23M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 28, 2022 · 87 d after period end
